THE EFFECT OF TOFACITINIB ON SERUM LIPIDS AND CARDIOVASCULAR SAFETY IN PATIENTS WITH ULCERATIVE COLITIS - RESULTS FROM THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAM

被引：0
|
作者：
Sands, Bruce E.
Taub, Pam R.
Feagan, Brian G.
Armuzzi, Alessandro
Friedman, Gary S.
Moscariello, Michele
Lawendy, Nervin
Pedersen, Ronald D.
Chan, Gary
Nduaka, Chudy I.
Quirk, Daniel
Salese, Leonardo
Su, Chinyu
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1750
引用
收藏
页码：S380 / S380
页数：1
相关论文
共 50 条
  • [31] Analysis of Infections of Interest in Patients Treated with Tofacitinib in the Ulcerative Colitis Clinical Program
    Chiorean, Michael V.
    Ha, Christina
    Armuzzi, Alessandro
    Lawendy, Nervin
    Mundayat, Rajiv
    Salese, Leonardo
    Woolcott, John C.
    Su, Chinyu
    Dotan, Iris
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S406 - S406
  • [32] Clostridium difficile Infection in Patients Treated With Tofacitinib in the Ulcerative Colitis Clinical Program
    Loftus, Edward V.
    Armuzzi, Alessandro
    Baumgart, Daniel C.
    Gecse, Krisztina B.
    Connelly, Susan B.
    Su, Chinyu
    Kwok, Kenneth K.
    Guo, Xiang
    Kinnucan, Jami A. R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S436 - S436
  • [33] Association between smoking status and the efficacy and safety of tofacitinib in patients with Ulcerative Colitis: Data from the tofacitinib clinical programme
    Rubin, D. T.
    Torres, J.
    Regueiro, M.
    Reinisch, W.
    Prideaux, L.
    Kotze, P. G.
    Tan, F. H.
    Gardiner, S.
    Mundayat, R.
    Cadatal, M. J.
    Ng, S. C.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I506 - I507
  • [34] Association between smoking status and the efficacy and safety of tofacitinib in patients with Ulcerative Colitis: Data from the tofacitinib clinical programme
    Rubin, D. T.
    Torres, J.
    Regueiro, M.
    Reinisch, W.
    Prideaux, L.
    Kotze, P. G.
    Tan, F. H.
    Gardiner, S.
    Mundayat, R.
    Cadatal, M. J.
    Ng, S. C.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I506 - I507
  • [35] Tofacitinib, vedolizumab and ustekinumab in patients with ulcerative colitis
    Chang, Hui-Chin
    Gau, Shuo-Yan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (11-12) : 1242 - 1242
  • [36] The role and prospect of tofacitinib in patients with ulcerative colitis
    Lee, Jun
    INTESTINAL RESEARCH, 2022,
  • [37] Tofacitinib in Ulcerative Colitis-evolving Efficacy and Safety
    Tiwari, Avinash
    Ashraf, Aadil
    Bharali, Pankaj
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2023, 57 (04) : 429 - 429
  • [38] Clostridium difficile Infection in Patients With Ulcerative Colitis Treated With Tofacitinib in the Ulcerative Colitis Program: An Update as of May 2019
    Loftus, Edward V., Jr.
    Armuzzi, Alessandro
    Baumgart, Daniel C.
    Curtis, Jeffrey R.
    Kinnucan, Jami A.
    Koram, Nana
    Salese, Leonardo
    Su, Chinyu
    Kwok, Kenneth
    Woolcott, John C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S333 - S334
  • [39] Tofacitinib for the Treatment of Ulcerative Colitis: Up to 9.2 Years of Safety Data From the Global Clinical Program
    Panes, Julian
    D'Haens, Geert R.
    Sands, Bruce E.
    Ng, Siew C.
    Lawendy, Nervin
    Kulisek, Nicole
    Guo, Xiang
    Wu, Joseph
    Vranic, Ivana
    Panaccione, Remo
    Vermeire, Severine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S910 - S910
  • [40] Efficacy of tofacitinib treatment in ulcerative colitis
    Panes, Julian
    Gisbert, Javier P.
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2019, 42 (06): : 403 - 412
12345